Logo

2022 QIPSS - Group 2 - Shared screen with speaker view
Jenny (Jingjing) Chen
16:20
Hey guys, can you hear me ok?
Javier Lorenzo
20:20
Dr. Ahuja is also here as lead Judge!
Lisa Shieh
21:57
Judges- please put your questions in the chat
lauren eggert
24:59
why would a CDA not fire?
Javier Lorenzo
25:49
was there any geographic patterns in patients that had a deterioration event with no CDA fire?
Pranjal Gupta
27:39
thanks all. have to head to shift but rob can answer more questions in his later discussion!
Javier Lorenzo
31:31
Were there any changes to the CMQCC guidelines for VTE based on the new published data?
Jenny (Jingjing) Chen
32:36
1min
Jenny (Jingjing) Chen
39:42
1min
Javier Lorenzo
40:03
Can this game be played in a mobile platform?
Neera Ahuja
41:10
What was the time frame of the intervention? (Specifically, since SQ has existed since 2018, did Covid make it more popular, unchanged?)
Javier Lorenzo
41:54
would be great to assess knowledge retention on this group of learners…
Abbie Hageman (she/her)
44:45
I have to run to the OR but thank you everyone for your time. Wish I could listen in on more presentations.
Jenny (Jingjing) Chen
47:13
1 min remaining
Javier Lorenzo
47:33
Is the reminder on Epic a BPA (best practice advisory?) that fired on patients that have been on steroids for more than 3 months? How is the Epic order set reminding physicians?
Jenny (Jingjing) Chen
53:47
1min remaining
Javier Lorenzo
55:19
This work highlights the complexity of specialty pharmacy dispensing. Phase 3 is taking too long. Can you comment on the ‘low hanging fruits’ you have identified?
Jenny (Jingjing) Chen
55:55
1min over time
Neera Ahuja
56:05
Do you feel these 4 interventions are expandable to administration of many other medications and, if so, do you plan to scale?
Shenee' (Sha-nay) Laurence
56:45
Have the implemented interventions shown an impact of the waiting time for patients?
Shenee' (Sha-nay) Laurence
58:12
Hi Gida - can you put your responses in chat
lauren eggert
59:26
My understanding was SHC does not have enough beds to do inpatient hospice which has been one of the big barriers. Can you comment on this?
ghida elbanna
59:53
Yes, the we expect the 4 interventions to impact other types of biologics. There are currently other biologics used for HS that are non-FDA approved but we chose to start with Humira because it is is FDAR approved. We also expect our findings to impact other patients with other conditions that require biologics such as asthma, crohn's etc
ghida elbanna
01:01:04
we are unable to assess whether the implemented interventions have had an impact yet mainly because there are very few patients who have been prescribed Humira recently. we only prescribe it for HS stage II/III. we will need more time and patients to assess these interventions. thank you
Neera Ahuja
01:01:26
Thank you Ghida
Javier Lorenzo
01:02:09
Thank you Ghida. Very complex work glad you are shedding some light on this issue for our HS (and other Humira) patients.
Jenny (Jingjing) Chen
01:02:41
1min remaining
Jenny (Jingjing) Chen
01:04:48
1min over time
Jenny (Jingjing) Chen
01:06:00
please wrap up - 7 min total
Javier Lorenzo
01:06:04
Yes, comfort care is now added to the patient's Storyboard and should be easier to identify. Comfort Care is also available in columns in patient's list. Should be easier to do this prospective review now Adi. You did a lot of work during these 2 weeks. Thanks!
Neera Ahuja
01:06:53
Great that you included PAMF
lauren eggert
01:07:23
I think it's a great idea. Next step is to further assess barriers to it's use I think
Jenny (Jingjing) Chen
01:12:03
1min
Neera Ahuja
01:13:22
Upon completion of this project, do you still believe all ED folks should be educated in this skill or that the optimal safety of the patient will be in the hands of a 'super user’?
Carl Preiksaitis
01:14:00
The reality of ED training is lots of people need to be capable to practice in a place with no resources.
Neera Ahuja
01:15:20
Thanks Nicole
Jenny (Jingjing) Chen
01:20:22
1min remaining
Cliff Schmiesing
01:21:09
amazing work on a vexing problem. thank you.
Cliff Schmiesing
01:24:06
I think it has "legs”
Alpa Vyas
01:24:28
thank you all!
Alpa Vyas
01:24:31
great presetnations!
Neera Ahuja
01:24:32
Thank you all and to Jenny for facilitating so effectively!
Javier Lorenzo
01:24:39
Thank you all !
Jenny (Jingjing) Chen
01:25:31
https://stanforduniversity.qualtrics.com/jfe/form/SV_esSdXnEg4HAUeZ8
Jenny (Jingjing) Chen
01:27:59
I'm going to hop off but I will make Dr. Shieh the host.
Jenny (Jingjing) Chen
01:28:21
Thanks judges!
lauren eggert
01:28:38
make neera the host